Yiɣi chaŋ yɛligu maŋamaŋa puuni

vemurafenib

Paaji maa yaɣa maa bɛ saɣi dee zuliya nima zaa
Create an article

This is an automatic view based on data from Wikidata.
There is not a complete article yet, but you can help creating one.

This template is part of the ArticlePlaceholder extension. If you want to adjust it, please consider making your changes upstream.

chemical compound

External resources

Binsheli di niŋdi bini
/m/0hqvq1s[1]
Reaxys registry number
12833468[2]
PubChem CID
42611257[3][4]
MeSH descriptor ID
D000077484

Din yuli nyɛ: Vemurafenib

UniChem compound ID
649459[5]
Quora topic ID
Vemurafenib[6]
UNII
207SMY3FQT[7][4]
LiverTosi dalinli
Vemurafenib
PDB ligand ID
032
KEGG ID
D09996[2]
ATC code
L01XE15[8]
Guide to Pharmacology Ligand ID
5893[9]
DeCS dalinli
57657
OpenAlex ID
C2776131300[10]
ChEMBL ID
CHEMBL1229517[11]
DSSTox substance ID
DTXSID50238710[12][4]
CAS rigistibu kalinli
918504-65-1[2][13]
BBC binyɛra ID
513b52df-f7fb-4032-9537-4d0e25ce26f0[14]
InChIKey
GPXBXXGIAQBQNI-UHFFFAOYSA-N[3][15]
NDF-RT dalinli
N0000183250[16]
Human Metabolome Database ID
HMDB0259779[17][4]
PubChem BioAssay dalinli (AID)
1055888
ChEBI ID
63637[2][18]

mapping ŋmahin gbana: exact match

WikiProjectMed ID
Vemurafenib
SPLASH
splash10-0006-0024900000-4911e6c7ad52fd2c2896
National Drug Code
50242-090
SureChEMBL ID
SCHEMBL298931[4]
InChI
InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)[3]
HSDB ID
8143[19]
DSSTOX compound identifier
DTXCID00161201
Microsoft Academic ID
2776131300
PatientsLikeMe treatment ID
vemurafenib
UMLS CUI
C3192263
ECHA Substance Infocard ID
100.287.801
MedlinePlus drug identifier
a612009
PDB structure ID
3OG7[20]
5HES[21]
4RZV[22]
ChemSpider ID
24747352[23]
EC lamba
850-250-7
MeSH tia code
D02.065.884.919
D02.886.590.700.919
D03.633.100.473.936
DrugCentral ID
4185[5]
World Health Organisation international non-proprietary name numeric ID
9286
DrugBank ID
08881[24]
DB08881[4]
RxNorm ID
1147220
Probes And Drugs ID
PD003414

buɣusi la

type of chemical entity

yaɣ sheli

chemical compound

Di bukaata

tima

tima yaɣa

timsim

489.073 dalton[3]

chemical formula

C₂₃H₁₈ClF₂N₃O₃S[3]

canonical SMILES

CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F[3]

active ingredient in

Zelboraf[25]

World Health Organisation international non-proprietary name

vemurafenib[2]

medical condition treated

hairy cell leukemia[26]
metastatic melanoma[26]
skin cancer[26]
Erdheim-Chester disease[26]
melanoma[26]

significant drug interaction

efavirenz[27]

barina: long QT syndrome

theophylline monohydrate[27]

barina: Achor-Smith syndrom

fosphenytoin[27]

barina: long QT syndrome

taba laɣim di fiila

B-Raf proto-oncogene, serine/threonine kinase[28]

bachikpani mali tuma: enzyme inhibitor

Raf-1 proto-oncogene, serine/threonine kinase[28]

bachikpani mali tuma: enzyme inhibitor

pregnancy category

Australian pregnancy category D
US pregnancy category D

LiverTox likelihood score

LiverTox toxicity likelihood category E*[29]

bachikpani mali tuma

antineoplastic[30]
protein kinase inhibitors[31]
xenobiotic-transporting ATPase inhibitor[31]
enzyme inhibitor[30]

pubu Commons ni

Vemurafenib

Reference

  1. ↑ Freebase Data Dumps, 28 Silimin gɔli October 2013
  2. ↑ 2.0 2.1 2.2 2.3 2.4 ChEBI, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 63637
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 PubChem, 18 Silimin gɔli October 2016, Silmiinsili, 42611257, Vemurafenib
  4. ↑ 4.0 4.1 4.2 4.3 4.4 4.5 GPXBXXGIAQBQNI-UHFFFAOYSA-N, InChIKey
  5. ↑ 5.0 5.1 UniChem
  6. ↑ Quora
  7. ↑ Global Substance Registration System, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 207SMY3FQT
  8. ↑ DrugBank, Silmiinsili, 17 Silimin gɔli November 2015, 08881, Vemurafenib
  9. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 18 Silimin gɔli October 2016, Silmiinsili, 5893, vemurafenib
  10. ↑ OpenAlex, 26 Silimin gɔli January 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  11. ↑ ChEMBL, 18 Silimin gɔli October 2016, Silmiinsili, VEMURAFENIB, CHEMBL1229517
  12. ↑ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  13. ↑ CAS Common Chemistry, 8 Silimin gɔli April 2021, GPXBXXGIAQBQNI-UHFFFAOYSA-N, https://commonchemistry.cas.org/detail?cas_rn=918504-65-1
  14. ↑ BBC Things
  15. ↑ ChEBI release 2020-09-01
  16. ↑ NDF-RT, 19 Silimin gɔli January 2016, Silmiinsili, VEMURAFENIB, N0000183250
  17. ↑ inferred from InChIKey
  18. ↑ International Chemical Identifier, InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)
  19. ↑ Hazardous Substances Data Bank, 10 Silimin gɔli May 2021, 28 Silimin gɔli October 2019, Vemurafenib, 8143
  20. ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 3OG7, 3OG7
  21. ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 5HES, 5HES
  22. ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 4RZV, 4RZV
  23. ↑ ChemSpider, 18 Silimin gɔli October 2016, Silmiinsili, 24747352, Vemurafenib
  24. ↑ DrugBank, 18 Silimin gɔli October 2016, Silmiinsili, 08881, Vemurafenib
  25. ↑ RxNorm, 1147224, 14 Silimin gɔli February 2018
  26. ↑ 26.0 26.1 26.2 26.3 26.4 Drug Indications Extracted from FAERS, 2 Silimin gɔli October 2018
  27. ↑ 27.0 27.1 27.2 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
  28. ↑ 28.0 28.1 IUPHAR/BPS Guide to PHARMACOLOGY, 17 Silimin gɔli August 2016, 5893, Silmiinsili
  29. ↑ LiverTox, 8 Silimin gɔli April 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Vemurafenib, 28 Silimin gɔli June 2018
  30. ↑ 30.0 30.1 Medical Subject Headings, 15 Silimin gɔli March 2018, C551177
  31. ↑ 31.0 31.1 N0000183250, 5 Silimin gɔli March 2018, NDF-RT
Di yila "https://dag.wikipedia.org/wiki/Diŋ%27gahim:AboutTopic/Q423111"